Lachey Jennifer
Chief Scientific Officer at KROS
- Sold, on record
- $6.3M
- Dollars the filings state
- Form 4 sales
- 17
- Latest Jul 15, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- KROSKeros Therapeutics, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale KROSPlan not statedJan 11, 2022 2022
Sold 2,650 shares at $53.75 ($142k)
Lachey Jennifer, Chief Scientific Officer
Sold 3% of holdings ($4.7M position)85,700 shares left0.5x usual sizeFiling
- 2 Form 4 sale KROSPlan not statedFeb 11, 2022 +31 days
Sold 2,650 shares at $52.06 ($138k)
Lachey Jennifer, Chief Scientific Officer
Sold 3% of holdings ($4.6M position)85,700 shares left0.7x usual sizeFiling
- 3 Form 4 sale KROSPlan not statedMar 11, 2022 +28 days
Sold 2,650 shares at $53.38 ($141k)
Lachey Jennifer, Chief Scientific Officer
Sold 3% of holdings ($4.7M position)85,700 shares left1x usual sizeFiling
- 4 Form 4 sale KROSUnusualApr 4, 2022 +24 days
Sold 7,950 shares at $60.00 ($477k)
Lachey Jennifer, Chief Scientific Officer
Sold 8.5% of holdings ($5.6M position)85,700 shares left3x usual sizeFiling
- 5 Form 4 sale KROSPlan not statedApr 11, 2022 +7 days
Sold 5,300 shares at $62.77 ($333k)
Lachey Jennifer, Chief Scientific Officer
Sold 5.8% of holdings ($5.7M position)85,700 shares left2x usual sizeFiling
- 6 Form 4 sale KROSPlan not statedMay 11, 2022 +30 days
Sold 5,300 shares at $41.90 ($222k)
Lachey Jennifer, Chief Scientific Officer
Sold 5.8% of holdings ($3.8M position)85,700 shares left1.3x usual sizeFiling
- 7 Form 4 sale KROSPlan not statedJul 13, 2022 +63 days
Sold 1,916 shares at $30.00 ($57k)
Lachey Jennifer, Chief Scientific Officer
Sold 2% of holdings ($2.9M position)95,100 shares left0.4x usual sizeFiling
- 8 Form 4 sale KROSUnusualJul 15, 2022 +2 days
Sold 46,034 shares at $30.00 ($1.4M)
Lachey Jennifer, Chief Scientific Officer
Sold 32.6% of holdings ($4.2M position)95,100 shares left11.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (17)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2022 | Jul 19, 2022 | KROS | Chief Scientific Officer | Form 4 sale | 46,034 | $1.4M | 32.6% | Unusual | SEC |
| Jul 13, 2022 | Jul 15, 2022 | KROS | Chief Scientific Officer | Form 4 sale | 1,916 | $57k | 2.0% | Plan not stated | SEC |
| May 11, 2022 | May 13, 2022 | KROS | Chief Scientific Officer | Form 4 sale | 5,300 | $222k | 5.8% | Plan not stated | SEC |
| Apr 11, 2022 | Apr 13, 2022 | KROS | Chief Scientific Officer | Form 4 sale | 5,300 | $333k | 5.8% | Plan not stated | SEC |
| Apr 4, 2022 | Apr 6, 2022 | KROS | Chief Scientific Officer | Form 4 sale | 7,950 | $477k | 8.5% | Unusual | SEC |
| Mar 11, 2022 | Mar 15, 2022 | KROS | Chief Scientific Officer | Form 4 sale | 2,650 | $141k | 3.0% | Plan not stated | SEC |
| Feb 11, 2022 | Feb 15, 2022 | KROS | Chief Scientific Officer | Form 4 sale | 2,650 | $138k | 3.0% | Plan not stated | SEC |
| Jan 11, 2022 | Jan 13, 2022 | KROS | Chief Scientific Officer | Form 4 sale | 2,650 | $142k | 3.0% | Plan not stated | SEC |
| Jan 5, 2022 | Jan 7, 2022 | KROS | Chief Scientific Officer | Form 4 sale | 2,650 | $159k | 3.0% | Plan not stated | SEC |
| Dec 15, 2021 | Dec 15, 2021 | KROS | Chief Scientific Officer | Form 4 sale | 2,650 | $134k | 3.0% | Plan not stated | SEC |
| Nov 11, 2021 | Nov 12, 2021 | KROS | Chief Scientific Officer | Form 4 sale | 21,200 | $1.3M | 19.8% | Unusual | SEC |
| Nov 4, 2021 | Nov 5, 2021 | KROS | Chief Scientific Officer | Form 4 sale | 10,600 | $530k | 11.0% | Plan not stated | SEC |
| Jun 11, 2021 | Jun 15, 2021 | KROS | Chief Scientific Officer | Form 4 sale | 2,650 | $135k | 3.3% | Plan not stated | SEC |
| May 11, 2021 | May 13, 2021 | KROS | Chief Scientific Officer | Form 4 sale | 2,650 | $133k | 3.6% | Plan not stated | SEC |
| Apr 12, 2021 | Apr 14, 2021 | KROS | Chief Scientific Officer | Form 4 sale | 5,300 | $318k | 6.9% | Plan not stated | SEC |
| Mar 11, 2021 | Mar 15, 2021 | KROS | Chief Scientific Officer | Form 4 sale | 5,300 | $342k | 8.0% | Plan not stated | SEC |
| Feb 11, 2021 | Feb 16, 2021 | KROS | Chief Scientific Officer | Form 4 sale | 5,300 | $344k | 15.9% | Plan not stated | SEC |